Free Trial

Global Cord Blood (CORBF) Competitors

$0.85 +0.30 (+54.55%)
As of 05/22/2025 02:55 PM Eastern

CORBF vs. TALK, LFMD, CSTL, PSNL, FTRE, CELC, SBC, VMD, AIRS, and TOI

Should you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Talkspace (TALK), LifeMD (LFMD), Castle Biosciences (CSTL), Personalis (PSNL), Fortrea (FTRE), Celcuity (CELC), SBC Medical Group (SBC), Viemed Healthcare (VMD), AirSculpt Technologies (AIRS), and Oncology Institute (TOI). These companies are all part of the "healthcare" industry.

Global Cord Blood vs.

Talkspace (NASDAQ:TALK) and Global Cord Blood (NYSE:CORBF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Talkspace has a net margin of 0.61% compared to Global Cord Blood's net margin of 0.00%. Talkspace's return on equity of 0.98% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Talkspace0.61% 0.98% 0.84%
Global Cord Blood N/A N/A N/A

Talkspace received 6 more outperform votes than Global Cord Blood when rated by MarketBeat users.

CompanyUnderperformOutperform
TalkspaceOutperform Votes
6
40.00%
Underperform Votes
9
60.00%
Global Cord BloodN/AN/A

In the previous week, Talkspace had 3 more articles in the media than Global Cord Blood. MarketBeat recorded 3 mentions for Talkspace and 0 mentions for Global Cord Blood. Talkspace's average media sentiment score of 1.49 beat Global Cord Blood's score of 0.00 indicating that Talkspace is being referred to more favorably in the media.

Company Overall Sentiment
Talkspace Positive
Global Cord Blood Neutral

57.4% of Talkspace shares are held by institutional investors. 23.5% of Talkspace shares are held by insiders. Comparatively, 0.5% of Global Cord Blood shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Global Cord Blood has higher revenue and earnings than Talkspace.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talkspace$194.36M2.38-$19.18M$0.02138.00
Global Cord Blood$196.12M0.53$79.04MN/AN/A

Talkspace has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.68, suggesting that its share price is 168% less volatile than the S&P 500.

Talkspace presently has a consensus target price of $4.50, suggesting a potential upside of 63.04%. Given Talkspace's stronger consensus rating and higher possible upside, equities analysts plainly believe Talkspace is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Talkspace
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Talkspace beats Global Cord Blood on 14 of the 16 factors compared between the two stocks.

Get Global Cord Blood News Delivered to You Automatically

Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CORBF vs. The Competition

MetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$103.32M$2.03B$5.33B$19.29B
Dividend YieldN/A6.96%5.21%3.83%
P/E RatioN/A15.8626.7734.52
Price / Sales0.533.58393.2734.82
Price / Cash1.409.3238.2517.51
Price / BookN/A3.926.774.69
Net Income$79.04M$87.49M$3.23B$1.02B
7 Day Performance-19.05%-4.19%0.43%-2.43%
1 Month Performance-10.53%-6.42%9.07%6.27%
1 Year Performance-29.17%-28.11%18.57%5.78%

Global Cord Blood Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CORBF
Global Cord Blood
N/A$0.85
+54.5%
N/A-29.2%$103.32M$196.12M0.001,200Gap Up
TALK
Talkspace
3.7243 of 5 stars
$2.95
-1.9%
$4.50
+52.3%
+0.0%$492.74M$194.36M294.79500Positive News
LFMD
LifeMD
1.4227 of 5 stars
$10.38
-1.9%
$11.00
+6.0%
+47.6%$471.93M$234.01M-16.23230News Coverage
Positive News
Gap Down
CSTL
Castle Biosciences
3.0152 of 5 stars
$16.35
-0.3%
$37.50
+129.4%
-35.1%$470.64M$347.08M81.51540Positive News
Analyst Forecast
PSNL
Personalis
4.3381 of 5 stars
$4.95
-1.4%
$7.67
+54.9%
+197.1%$435.44M$85.69M-2.93400
FTRE
Fortrea
3.4151 of 5 stars
$4.74
+6.6%
$15.00
+216.3%
-83.9%$428.07M$2.69B-1.3918,000Positive News
Analyst Forecast
CELC
Celcuity
1.9193 of 5 stars
$10.56
-1.2%
$30.80
+191.7%
-32.8%$400.90MN/A-4.0640Trending News
Analyst Revision
SBC
SBC Medical Group
N/A$3.53
+3.5%
N/AN/A$365.75M$205.42M0.00N/ANews Coverage
Analyst Revision
High Trading Volume
VMD
Viemed Healthcare
2.4487 of 5 stars
$6.80
+0.7%
N/A-7.3%$268.53M$232.79M25.16630Positive News
AIRS
AirSculpt Technologies
0.4304 of 5 stars
$3.82
+7.3%
$3.75
-1.8%
+24.2%$223.60M$172.10M-27.17240Gap Up
High Trading Volume
TOI
Oncology Institute
2.2358 of 5 stars
$2.93
-4.2%
$7.00
+138.9%
+424.5%$221.77M$393.41M-3.76660Insider Trade

Related Companies and Tools


This page (NYSE:CORBF) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners